代表学术论文
1. 陈勇军, 唐启彬, 邹声泉. 散发性肝外胆管癌中RASSF1A基因启动子甲基化状态研究.中华实验外科杂志.2004,21(12):1430-1432.
2. 陈勇军, 唐启彬, 邹声泉. RASSF1基因在肝外胆管癌组织中转录表达及其临床意义的研究.中华肝胆外科杂志.2005,11(2):107-109.
3. Chen YJ, Tang QB, Zou SQ. Inactivation of RASSF1A,the tumor suppressor gene at chromosome 3p21.3 in extrahepatic cholangiocarcinoma. World J Gastroenterology. 2005, 11(9): 1333-1338.
4. 陈勇军, 唐启彬, 王剑明, 邹声泉. 肝外胆管癌染色体3p21.3区段微卫星不稳定和杂合性缺失分析.中华实验外科杂志. 2005,22(12): 1474 - 1476.
5. 陈勇军, 唐启彬, 王剑明, 邹声泉. 5-氮-2-脱氧胞苷联合曲古抑菌素A在体内、体外对人胆管癌细胞QBC-939增殖的影响。中华肝胆外科杂志. 2006, 12(8):547-549.
6. 陈勇军, 唐启彬, 王剑明, 邹声泉. 肝外胆管癌染色体3p21.3区段遗传不稳定性分析.中国肿瘤临床. 2006, 33(20): 1146-1149.
7. 陈勇军, 唐启彬, 王剑明, 邹声泉. 肝外胆管癌瘤细胞染色体的结构畸变.华中科技大学学报(医学版).2007, 36(3): 307-309.
8. 陈勇军, 陈波, 王剑明, 邹声泉. 组蛋白甲基转移酶基因G9a在肝外胆管癌组织中转录表达及其临床意义的研究.中华肝胆外科杂志. 2007, 13(7): 460-462.
9. 陈勇军, 罗剑, 郑建伟, 陈波, 王剑明, 邹声泉. G9a 特异性siRNA表达载体的构建及在QBC939细胞中对G9a基因表达的影响.中华普通外科杂志.2007, 22(7): 530-532.
10. Yongjun C, Jian L, Bo C, Jianming W, Shengquan Z. Expression of histone methyl- transferase G9a and clinical significance in extrahepatic cholangiocarcinoma. Chinese-German Journal of Clinical Oncology. 2008, 7(1): 10-13.
11. 陈勇军,罗剑,陈波,李宏,王剑明,邹声泉.pSi2.1-G9a-siRNA诱导人胆管癌细胞RASSF1A基因脱甲基化.中华实验外科杂志 .2008, 25(10): 1229-1231.
12. Chen Y, Gao W, Luo J, Tian R, Sun H, Zou S. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma. Oncol Rep. 2011, 25(2):443-51.
13. Chen Y, Luo J, Tian R, Sun H, Zou S. miR-373 Negatively Regulates Methyl-CpG-Binding Domain Protein 2 (MBD2) in Hilar Cholangiocarcinoma. Dig Dis Sci. 2011;56(6): 1693-701.
14. Chen YJ, Luo J, Yang GY, Yang K, Wen SQ, Zou SQ.Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma. World J Gastroenterol. 2012;18(29):3849-61.
15. Yongjun Chen, Renyi Qin, Xiaoping Chen. Laparoscopic hepato-biliary-pancreatic surgery: present practices and prospects. Frontiers of medicine. 2011;5(3):235-238.
16. 杨光耀,杨康,温松奇,俞亚红,丁志强,陈勇军. 核酸内切酶在肝门部胆管癌组织和细胞株中的表达和临床意义.中华肝胆外科杂志, 2012; 18(10): 753-757. (通讯作者)
17. Yongjun Chen, Bo-Chul Shin, Shanthie Thamotharan, and Sherin U. Devaskar. Creb1-Mecp2-mCpG Complex Transactivates Postnatal Murine Neuronal Glucose Transporter Isoform 3 Expression. Endocrinology. 2013; 154(4): 1598-1611.
18. 陈勇军,田锐,王敏,石程剑,秦仁义,邹声泉.胰管结石的分型及外科治疗方式的选择. 中华外科杂志. 2013,51(8): 688-690.
19. Chen Y, Shin BC, Thamotharan S, Devaskar SU. Differential methylation of the micro-RNA 7b gene targets postnatal maturation of murine neuronal Mecp2 gene expression. Dev Neurobiol. (2013 Sep 4).
20. 陈勇军,田礼,胡走肖,刘永,邹声泉.微小RNA-373在肝门部胆管癌细胞中的表达和靶向甲基CpG结合蛋白2的作用.中华实验外科杂志.2013,30(11):2255-2257.
21. Cheng W, Tian L, Wang B, Qi Y, Huang W, Li H, Chen YJ. Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression. Oncotarget. 2016,26;7(30):48107-19. (通讯作者)
22. Cheng W, Qi Y, Wang B, Tian L, Huang W, Chen Y. Characteristics and computed tomography evaluation of primary retroperitoneal tumours: report of 113 cases. Ann R Coll Surg Engl. 2017;99(1):55-9. (通讯作者)
23. Cheng WL, Qi YQ, Wang B, Tian L, Huang W, Chen Y. Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis. Ann R Coll Surg Engl. 2017;99(3):237-241. (通讯作者)
24. Cheng W, Qi Y, Tian L, Wang B, Huang W, Chen Y.Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells. Cell Death Dis. 2017 Feb 23;8(2):e2628.(通讯作者)